SCHEMBL30133987

SCHEMBL30133987

O=C(O)c1ccc(CN2CCC(F)(F)CC2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.47
HIF1A Q16665 1/20 0.43
EPAS1 Q99814 1/20 0.43
PRMT5 O14744 2/20 0.42
WDR77 Q9BQA1 2/20 0.42
KDM5C P41229 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
P4HA1 P13674 2/20 0.40
P4HTM Q9NXG6 2/20 0.40
CNR1 P21554 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
HCAR3 P49019 6/20 0.40
HCAR2 Q8TDS4 1/20 0.40
MIF P14174 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24214179 0.86 HRH3 (0.43) HRH3HIF1AEPAS1PRMT5WDR77
SCHEMBL31043166 0.84 HRH3 (0.46) HRH3HIF1AEPAS1PRMT5WDR77
SCHEMBL18547311 0.81 HRH3 (0.47) HRH3HIF1AEPAS1KDM5CKDM4C
SCHEMBL2305325 0.80 HRH3 (0.62) HRH3HIF1AEPAS1KDM5CKDM4C
SCHEMBL17075537 0.79 HRH3 (0.61) HRH3HIF1AEPAS1KDM5CKDM4C
SCHEMBL13460107 0.77 CHRM2 (0.47) HRH3CNR1CHRM2CHRM1CHRM3
SCHEMBL12965907 0.76 KDM4E (0.45) HRH3HIF1AEPAS1KDM5CKDM4C
SCHEMBL24214234 0.75 ADRA1A (0.52) HRH3P4HA1P4HTMHCAR3MIF
SCHEMBL24214216 0.75 CNR1 (0.41) KDM5CKDM4CCNR1
SCHEMBL14825456 0.74 ATM (0.54) HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK HRH3 1784/4885HIF1A 3188/4885EPAS1 2278/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK HRH3 1784/4885HIF1A 3188/4885EPAS1 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.